Medical Device News Magazine spoke with CEO Mark Goldwasser about the potential of the medtech sector, companies that Ceros has funded so far, and what he sees ahead.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.